Financhill
Back

Novo Nordisk AS Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
36

NONOF
Novo Nordisk AS

Last Price:
110.70
Seasonality Move:
9.66%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Novo Nordisk AS Price Quote

$110.70

Novo Nordisk AS Key Stats

Sell
36
Novo Nordisk AS (NONOF) is a Sell

Day range:
$102.90 - $111.20
52-week range:
$93.80 - $149.55
Dividend yield:
1.31%
P/E ratio:
40.95
P/S ratio:
12.57
P/B ratio:
27.29%

Volume:
14.1K
Avg. volume:
48K
1-year change:
8.8%
Market cap:
$492.6B
Revenue:
$33.7B
EPS:
$3.09

How Much Does Novo Nordisk AS Make?

Is Novo Nordisk AS Growing As A Company?

  • What Is Novo Nordisk AS's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.23%
  • What Is Novo Nordisk AS's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.24%

Novo Nordisk AS Stock Price Performance

  • Did Novo Nordisk AS Stock Go Up Last Month?
    Novo Nordisk AS share price went down by -4.36% last month
  • Did NONOF's Share Price Rise Over The Last Year?
    NONOF share price rose by 8.8% over the past 1 year

What Is Novo Nordisk AS 52-Week High & Low?

Novo Nordisk AS Price To Free Cash Flow

Is It Risky To Buy Novo Nordisk AS?

  • How Much Debt Does Novo Nordisk AS Have?
    Total long term debt quarterly is $8.5B
  • How Much Cash Does Novo Nordisk AS Have?
    Cash and short term investments quarterly total is $11.2B
  • What Is Novo Nordisk AS’s Book Value Per Share?
    Book value per share is 4.06

Is Novo Nordisk AS Cash Flow Positive?

  • What Is NONOF Cash Flow From Operations?
    Cash flow from operations (TTM) is $17.3B
  • What Is Novo Nordisk AS’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$5.6B
  • What Is Novo Nordisk AS’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$7.7B

Novo Nordisk AS Return On Invested Capital

  • Is Management Doing A Good Job?
    NONOF return on invested capital is 65.63%
  • What Is Novo Nordisk AS Return On Assets?
    ROA measures how assets are converting to revenues and is 28.14%
  • What Is NONOF Return On Equity?
    ROE is a measure of profitability and is 88.95%

Novo Nordisk AS Earnings Date & Stock Price

Novo Nordisk AS Competitors

Novo Nordisk AS Dividend Yield

Novo Nordisk AS Analyst Estimates

YoY Growth Past Surprise
EPS: 23.52% 0%
Revenue: 22.53% -0.31%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 95.19
Downside from Last Price: -14.01%

Major Shareholders

  • How many NONOF shares are owned by institutional investors?
    786.4M NONOF shares are owned by institutional investors
  • How many NONOF shares are owned by insiders?
    0 NONOF shares are owned by insiders